Abnormal lipid levels are a significant risk factor for atherosclerosis that originates in childhood. This risk factor can be identified and managed early on in childhood to reduce the cardiovascular disease (CVD) burden. The AAP recommends universal lipid screening of all children and adolescents between ages 9-11 and 17-21 years. Targeted screening is not adequate due to the increased prevalence of obesity and dyslipidemia. Using family history of premature CVD alone misses 30-60% of children with dyslipidemia.
 

Main Guideline  LDL Algorithm  TG Algorithm
 

Handouts for Patient Families

References

These guidelines are intended solely for the use of healthcare professionals who are licensed to practice medicine. This material is not intended to replace professional medical judgment, prescribing information or consultation with a medical professional. Any health care provider using this material acknowledges full responsibility for the medical care and treatment of patients. All health care providers are solely responsible for confirming the accuracy, timeliness, completeness, appropriateness and helpfulness of this material and making all medical, diagnostic or prescription decisions.

For questions about the guidelines, CLASP [at] Connecticutchildrens.org (email the CLASP team).